Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases ...

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Vitiligo is a long-term skin condition where certain areas lose their natural color and turn noticeably lighter than the ...

Mattel says it developed the new Barbie in partnership with a nonprofit organization that advocates for the rights and better ...

Incyte’s The Power of Choice campaign was supported by two 2025 MM+M Agency 100 honorees: Klick and Real Chemistry.

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Associate Professor Viktoria Eleftheriadou discusses the launch of the UK’s first vitiligo registry as part of the VIRTUAL-UK pilot study.

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

The company is consolidating its operations in Vadodara, with US headcount slashed by over 80 percent, labs reduced from four ...